BioKuris SA
1.0 FTEBioKuris reported revenue of 700,235 € for the 2025 financial year (annual accounts filed with the NBB on 28 May 2026), with 1 full-time equivalent.
The score of BioKuris shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +400 % Equity -77 % Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BioKuris's annual accounts
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | 700,235 € | |||
| Net result | −€1.68m | |||
| Equity | €1.05m | |||
| Cash | 223,006 € | |||
| EBITDA | −570,795 € | |||
| Total assets | €5.85m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 May 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
BioKuris's financial analysis
- Solvency18.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BioKuris
BioKuris's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0769.454.379
- VAT number
- BE0769454379
- Peppol
- Registered · 0208:0769454379 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 08 Jun 2021
- Registered office
- 4040 Herstal
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
BioKuris (SA) has been based in Herstal since 2021, active in: research and experimental development on biotechnology. For 2025, it reports revenue of 700,235 €, a net loss of €1.68m and equity of €1.05m. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.0%, below the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BioKuris
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Orionis Biosciences Research and experimental development on natural sciences and engineering Ghent · balance sheet €6.88m
- Hebrimo Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €4.71m
- CM4Cure Research and experimental development on natural sciences and engineering Liège · balance sheet €4.57m
- Cryoport Belgium Research and experimental development on natural sciences and engineering Villers-le-Bouillet · balance sheet €16.2m
- HepaVue Dx Research and experimental development on natural sciences and engineering Waterloo · balance sheet €3.71m
- Envitec Measurements and Analytics SA Research and experimental development on natural sciences and engineering Gembloux · balance sheet €3.64m
- K5 Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €3.56m
Frequently asked questions about BioKuris
What is the revenue of BioKuris?
According to the 2025 annual accounts filed with the NBB, the revenue of BioKuris amounts to 700,235 €.
What is the VAT number of BioKuris?
In Belgium, the VAT number is the company number prefixed with BE: BE0769454379 for BioKuris, if the company is VAT-registered. Its company number (CBE) is 0769.454.379.
Where is the registered office of BioKuris?
According to the CBE register, the registered office of BioKuris is in 4040 Herstal.
What is the equity of BioKuris?
At the close of the 2025 financial year, the equity of BioKuris amounts to 1,050,973 €, a solvency of 18.0% of total assets.
How many people work at BioKuris?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages BioKuris?
The register lists 9 active mandates at BioKuris. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BioKuris
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →